Why AbCellera Biologics Stock Jumped 19.4% Last Month
Shares of AbCellera Biologics (NASDAQ: ABCL) gained 19.4% in September, according to data from S&P Global Market Intelligence. The stock jumped in the middle of the month after the biotech company announced that it had formed a new partnership with Moderna and continued to climb after it detailed another new partnership with Everest Medicines.
Source Fool.com